News tagged with serious adverse events
Supplement mixture improves memory in mild Alzheimer's
(HealthDay) -- A supplement mixture (Souvenaid) containing dietary precursors and specific nutrients can improve memory in drug-naive patients with mild Alzheimer's disease (AD), according to a study published ...
Alzheimer's disease & dementia
Jul 12, 2012 |
4 / 5 (3) |
1
|
Landmark editorial denounces 'poor publication practices' in spine research
Loyola University Hospital spine surgeon Dr. Alexander Ghanayem is co-author of a landmark editorial challenging the integrity of published industry-sponsored research involving a bone-growth product.
Other
Jun 28, 2011 |
5 / 5 (2) |
0
Benefits of radionuclide therapy for neuroendocrine tumors
According to new Dutch research featured in the September issue of The Journal of Nuclear Medicine, a peptide receptor radiolabeled therapy (PRRT), [177Lu-DOTA0,Tyr3]Octreotate (177Lu-octreotate) , is effective not only i ...
Cancer
Sep 20, 2011 |
5 / 5 (2) |
1
First US embryonic stem cell trial is halted
The first-ever trial using human embryonic stem cells to treat paralysis has been halted due to high costs and the company will focus instead on new cancer treatments, Geron said Tuesday.
Medical research
Nov 15, 2011 |
2.5 / 5 (4) |
2
Phase I study of temsirolimus, capecitabine proves safe; positive survival trend seen
A phase I clinical trial examining the safety of combining temsirolimus and capecitabine in advanced malignancies suggests the two agents can be given safely to patients. In addition, the Georgetown Lombardi Comprehensive ...
Cancer
May 16, 2012 |
5 / 5 (1) |
0
High doses of saw palmetto appear safe over 18 months
(HealthDay)—Extracts of saw palmetto berry used at doses of up to 960 mg daily appear to be safe over an 18-month period, according to a study published in the April issue of The Journal of Urology.
Diseases, Conditions, Syndromes
Apr 29, 2013 |
5 / 5 (1) |
0
